FDA 801(a): What It Means When Your Cosmetic, Food, or Medical Device Shipment Is Refused

Your container of imported goods has been stopped at the U.S. border. You receive a notice citing Section 801(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), and suddenly your entire shipment is in jeopardy. 

For importers of cosmetics, food products, and medical devices, an 801(a) refusal is more than just a delay; it is a legal barrier that can lead to significant financial losses, supply chain disruptions, and long-term compliance challenges. Understanding this critical provision is the first step toward resolving the immediate problem and preventing it from happening again.

This guide provides a plain-language explanation of FDA 801(a), why it is used to refuse shipments, and what steps you can take to respond effectively. It is designed for brand owners and importers who need to navigate the complex intersection of FDA regulations and U.S. Customs procedures.

(Readers are encouraged to explore the Bustos Law Group solution for the product held at custom. We provide trusted solutions for compliance and release for the cosmetic, food, & medical devices industry.)

What Is FDA Section 801(a)?

Section 801(a) of the FD&C Act is the primary legal authority the U.S. Food and Drug Administration (FDA) uses to refuse admission of imported products that appear to violate U.S. law. The key phrase here is "appears to violate." The FDA does not need definitive proof that a product is non-compliant to refuse it. If the agency has evidence that suggests a violation, it can stop the product at the border.

This authority is broad and applies to a wide range of products, including:

• Cosmetics: Skincare, makeup, and other personal care products.

• Food: Including dietary supplements, beverages, and food ingredients.

• Medical Devices: From simple instruments to complex diagnostic equipment.

An 801(a) refusal is a final decision by the FDA that the product is not permitted to enter U.S. commerce.

How Section 801(a) Fits Into the FDA Import Process

When a shipment of regulated goods arrives at a U.S. port, it is subject to review by both U.S. Customs and Border Protection (CBP) and the FDA. 

The process generally follows these steps:

1. Entry Filing: The importer or their customs broker files entry documents with CBP.

2. FDA Screening: The FDA electronically screens the entry information to assess risk. Factors include the product type, manufacturer compliance history, and whether the product is subject to an Import Alert.

3. FDA Examination or Sampling: If the shipment is flagged, the FDA may conduct a field examination or collect a sample for laboratory analysis.

4. FDA Action: Based on the screening, examination, or sample results, the FDA will decide to either release the shipment or detain it.

5. Refusal Under 801(a): If the FDA determines the product appears to be in violation of the FD&C Act, it will issue a Notice of FDA Action refusing admission under Section 801(a).

FDA 801(a) vs. Detention and Import Alerts

It is crucial to understand the difference between a detention, an import alert, and an 801(a) refusal.

Term	Definition	Implication
Detention	A temporary hold placed on a shipment while the FDA gathers more information or conducts an examination.	The importer has an opportunity to provide evidence to overcome the appearance of a violation.
Import Alert	A public notice that the FDA has enough evidence to believe a future shipment of a specific product, manufacturer, or shipper is in violation. This often leads to Detention Without Physical Examination (DWPE).	Shipments are automatically detained until the importer proves compliance.
801(a) Refusal	A final decision that the product is inadmissible. This typically follows a detention where the importer failed to resolve the compliance issues.	The product cannot enter the U.S. and must be exported or destroyed.

In short, a detention is a temporary hold, an import alert is a standing warning, and an 801(a) refusal is the final verdict.

Common Violations Cited Under Section 801(a)

The FDA can refuse a product for numerous reasons. For cosmetics, food, and medical devices, the most common violations include:

• Adulteration: The product is contaminated, contains an unsafe substance, is manufactured in unsanitary conditions, or fails to meet safety standards.

• Misbranding: The product’s labeling is false, misleading, or incomplete. This includes unapproved health claims, incorrect ingredient lists, or failure to include required warnings.

• Unapproved New Drug: A product is marketed with claims that it can treat or prevent a disease, making it an unapproved new drug in the eyes of the FDA.

• Registration and Listing Failures: The manufacturing facility is not registered with the FDA, or the specific product is not listed as required (common for medical devices and some food facilities).

What Happens After an 801(a) Refusal?

Once a product is refused, the importer has a limited time (typically 90 days) to either export the shipment or have it destroyed under CBP supervision. Failure to do so can result in CBP seizing the goods and issuing a claim for liquidated damages, which can be up to three times the value of the shipment.

The financial impact is immediate and severe. The importer loses the value of the goods, the cost of shipping, and any potential revenue. Furthermore, a history of refusals can increase the likelihood of future shipments being detained.

How to Respond to an FDA 801(a) Action

While an 801(a) refusal is a final action on a specific shipment, it is critical to take steps to prevent it from happening again.

6. Review the Legal Basis for Refusal: Carefully read the Notice of FDA Action to understand the specific violation cited. This is the foundation for your corrective action plan.

7. Develop a Corrective Action Plan: Address the root cause of the violation. This may involve reformulating a product, redesigning a label, or improving manufacturing processes.

8. Prepare for Future Imports: Before shipping again, ensure that all compliance issues have been resolved. For products subject to an Import Alert, you may need to petition the FDA for removal, which often requires submitting evidence from five to fifteen compliant shipments.

When Regulatory and Legal Support Becomes Critical

Navigating an FDA 801(a) refusal is a complex process with significant legal and financial stakes. An experienced FDA regulatory attorney can be invaluable in these situations. Bustos Law Group helps importers by:

• Interpreting FDA Notices: We analyze the specific legal basis for the refusal and explain what it means for your business.

• Developing Compliance Strategies: We work with you to create and implement a robust corrective action plan to address the underlying violations.

• Communicating with the FDA: We can represent your interests in communications with the FDA, including filing petitions to be removed from an Import Alert.

• Preventing Future Issues: Our team provides proactive compliance reviews to help you avoid future detentions and refusals.

If your products have been refused under Section 801(a) or are being held at customs, do not wait. Contact Bustos Law Group today for a consultation to understand your options and protect your business.